Company profile: Sirigen
1.1 - Company Overview
Company description
- Provider of light-harvesting polymer materials and High Sensitivity Fluorescence (HSF) technology for diagnostic and life science applications. Offers HSF to enhance signals, lower detection limits and improve multiplexing; Brilliant Violet dyes for violet lasers and flow cytometry; and solutions for immunoassays/ELISA, biomarkers/proteomics, and lateral flow/point-of-care with simplified sample processing and instrumentation.
Products and services
- Brilliant Violet™ Dyes: Violet-laser-optimized fluorescent dye family delivering enhanced brightness, expanded color choices, and improved panel design and sensitivity for flow cytometry and other applications
- HSF™ (High Sensitivity Fluorescence™): Polymeric amplification system that boosts assay signals, lowers detection limits, simplifies sample prep/instrumentation, and expands multiplexing for immunodiagnostics, nucleic assays, biomarkers, and proteomics
- Immunoassay & ELISA: Homogeneous-protocol-compatible HSF-enabled fluorescent immunoassay platform supporting multiplexed assays with simplified sample processing and instrumentation and lower detection limits for diagnostic and life science applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sirigen
Breath Therapeutics
HQ: Germany
Website
- Description: Provider of inhaled investigational therapies for rare respiratory diseases, combining novel formulations of existing drugs with cutting-edge inhalation technology. Pipeline includes Liposomal Cyclosporine A for Inhalation for bronchiolitis obliterans syndrome to deliver drug to lungs while minimizing systemic exposure, and inhaled colistimethate sodium for non-cystic fibrosis bronchiectasis targeting Pseudomonas aeruginosa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Breath Therapeutics company profile →
Arima Genomics
HQ: United States
Website
- Description: Provider of 3D genomics solutions including Arima-HiC to capture chromatin organization, Arima Capture-HiC for high-resolution targeted chromatin conformation, and Arima-HiChIP for protein-DNA interaction analysis; plus genome assembly of reference-quality, chromosome-spanning assemblies, and cancer genomics and human health offerings delivering insights into disease mechanisms, biomarkers, and therapeutic targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arima Genomics company profile →
Savsu
HQ: United States
Website
- Description: Provider of integrated, innovative hardware and software solutions designed to protect live cell therapies during transport and storage, serving cell and gene therapy companies, specialty couriers, biotech/biopharma, research institutions, governments, and NGOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Savsu company profile →
Cardea Bio
HQ: United States
Website
- Description: Provider of graphene-based, biology-gated transistor infrastructure and biosensing solutions, including: BPU Platform converting biological interactions into electrical signals for real-time multiomics; graphene biosensors for direct biomolecule measurement; CRISPR-Chip for gene editing efficiency; and commercial/research partnerships across healthcare, agriculture, and environmental monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardea Bio company profile →
Molecular Devices
HQ: United States
Website
- Description: Provider of analytical solutions for cell and protein biology, enabling customers to unravel complex biological systems. Offerings include AI-driven automated cell culture (CellXpress.ai), high-content confocal imaging (ImageXpress), SpectraMax microplate readers, SoftMax Pro software for data analysis, GxP compliance solutions, and an Organoid Innovation Center for 3D biological models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Devices company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sirigen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sirigen
2.2 - Growth funds investing in similar companies to Sirigen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sirigen
4.2 - Public trading comparable groups for Sirigen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →